To kill a microRNA: emerging concepts in target-directed microRNA degradation
Nucleic Acids Research · 28.02.2024 · 52 (4) · 1558-1574
DOI: 10.1093/nar/gkae003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nucleic Acids Research, online erschienen am 15.01.2024. Verfasst von Amber F Buhagiar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Lab Medicine, Weill Cornell Medicine, New York, NY10065, USA. Hauptthemen laut MEDLINE: MicroRNAs, RNA Stability. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences, Weill Cornell Medicine Department of Pathology and Lab Medicine Faculty.
Abstract (Originalsprache)
MicroRNAs (miRNAs) guide Argonaute (AGO) proteins to bind mRNA targets. Although most targets are destabilized by miRNA–AGO binding, some targets induce degradation of the miRNA instead. These special targets are also referred to as trigger RNAs. All triggers identified thus far have binding sites with greater complementarity to the miRNA than typical target sites. Target-directed miRNA degradation (TDMD) occurs when trigger RNAs bind the miRNA–AGO complex and recruit the ZSWIM8 E3 ubiquitin ligase, leading to AGO ubiquitination and proteolysis and subsequent miRNA destruction. More than 100 different miRNAs are regulated by ZSWIM8 in bilaterian animals, and hundreds of trigger RNAs have been predicted computationally. Disruption of individual trigger RNAs or ZSWIM8 has uncovered important developmental and physiologic roles for TDMD across a variety of model organisms and cell types. In this review, we highlight recent progress in understanding the mechanistic basis and functions of TDMD, describe common features of trigger RNAs, outline best practices for validating trigger RNAs, and discuss outstanding questions in the field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Lab Medicine, Weill Cornell Medicine, New York, NY10065, USA.
ORCID-Profile: Amber F Buhagiar, Benjamin Kleaveland
Förderung
- NIGMS NIH HHS
- National Institute of General Medical Sciences
- Weill Cornell Medicine Department of Pathology and Lab Medicine Faculty
Zitieren
APA
Buhagiar, A. F., & Kleaveland, B. (2024). To kill a microRNA: emerging concepts in target-directed microRNA degradation. Nucleic Acids Research, 52(4), 1558-1574. https://doi.org/10.1093/nar/gkae003
Vancouver
Buhagiar AF, Kleaveland B. To kill a microRNA: emerging concepts in target-directed microRNA degradation. Nucleic Acids Research. 2024;52(4):1558-1574. doi:10.1093/nar/gkae003
BibTeX
@article{Buhagiar2024,
author = {Buhagiar, Amber F and Kleaveland, Benjamin},
title = {To kill a microRNA: emerging concepts in target-directed microRNA degradation},
journal = {Nucleic Acids Research},
year = {2024},
volume = {52},
number = {4},
pages = {1558--1574},
doi = {10.1093/nar/gkae003}
}
EUVIMED